| Literature DB >> 33997057 |
Hongzhi Liu1, Xinqiu Song2, Pei Liu3, Huachen Yu4, Qidong Zhang5,6, Wanshou Guo5,6.
Abstract
BACKGROUND: Controversy exists concerning whether tenotomy or tenodesis is the optimal surgical treatment option for proximal biceps tendon lesions.Entities:
Keywords: Biceps; arthroscopic; meta-analysis; tenodesis; tenotomy
Year: 2021 PMID: 33997057 PMCID: PMC8071980 DOI: 10.1177/2325967121993805
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Flowchart of the number of studies identified and included in this meta-analysis based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
Characteristics of Included Studies
| Lead Author (Year) | Study Design | LoE | Outcome Measures | Follow-up, mo | MCMS Score | |
|---|---|---|---|---|---|---|
| Tenotomy | Tenodesis | |||||
| MacDonald[ | RCT | 1 | 1, 5, 6 | 24 | 24 | 91 |
| Castricini[ | RCT | 1 | 1, 2, 3, 4, 5 | 12 | 12 | 94 |
| Lee[ | RCT | 1 | 1, 3 | 25.1 | 19.7 | 89 |
| Zhang[ | RCT | 1 | 1, 2, 4, 5, 7, 8 | 25 | 25 | 95 |
| Belay[ | RCT | 2 | 1, 2, 5 | 24 | 24 | 83 |
| Hufeland[ | RCT | 2 | 1, 2, 4, 6, 9 | 12 | 12 | 86 |
| Mardani-Kivi[ | RCT | 2 | 1, 2, 4, 9 | 24 | 24 | 87 |
| Oh[ | PCS | 2 | 1, 2, 3, 5, 6, 7, 8, 11, 12 | 21.98 | 21.46 | 84 |
| Kukkonen[ | PCS | 2 | 1, 2 | 24 | 24 | 86 |
| De Carli[ | PCS | 2 | 1, 4, 9 | 23 | 25 | 89 |
| Koh[ | PCS | 2 | 1, 2, 4, 6, 7 | 27.93 | 27.05 | 92 |
| Aflatooni[ | RCS | 3 | 1, 2 | 38.4 | 30.7 | 79 |
| Zhang[ | RCS | 3 | 1, 5, 10 | 14.3 | 14.3 | 70 |
| Kerschbaum[ | RCS | 3 | 1, 4 | 39 | 39 | 76 |
| Meraner[ | RCS | 4 | 1, 2, 4 | 34 | 34 | 76 |
| Cho[ | RCS | 3 | 1, 4, 10 | 24.2 | 26.1 | 79 |
| Biz[ | RCS | 3 | 1 | 30 | 30 | 71 |
| Ikemoto[ | RCS | 3 | 1 | 41.84 | 45.36 | 76 |
| Sentürk[ | RCS | 4 | 4, 10 | 37.2 | 37.2 | 70 |
| Wittstein[ | RCS | 3 | 1, 2, 6 | 57 | 58 | 63 |
| Boileau[ | RCS | 3 | 1, 2, 4, 11, 12 | 36 | 34 | 79 |
LoE, level of evidence; MCMS, modified Coleman Methodology Score; PCS, prospective cohort study; RCS, retrospective cohort study; RCT, randomized clinical trial.
Outcome measures: 1 = Popeye deformity; 2 = arm cramping pain; 3 = rotator cuff retear; 4 = Constant score; 5 = visual analog scale for pain; 6 = American Shoulder and Elbow Surgeons score; 7 = elbow flexion strength index; 8 = forearm supination strength index; 9 = Simple Shoulder Test; 10 = University of California, Los Angeles score; 11 = forward flexion; and 12 = external rotation at the side.
Characteristics of Study Patients
| Lead Author (Year) | Sample Size, n | Age, | Female Sex, n | |||
|---|---|---|---|---|---|---|
| Tenotomy | Tenodesis | Tenotomy | Tenodesis | Tenotomy | Tenodesis | |
| MacDonald[ | 57 | 57 | 56.3 ± 8.1 | 58.7 ± 10.9 | 12 | 10 |
| Castricini[ | 31 | 24 | 59.9 ± 8.0 | 57.1 ± 8.0 | 17 | 17 |
| Lee[ | 56 | 72 | 62.8 (55-77) | 62.9 (50-75) | 45 | 54 |
| Zhang[ | 77 | 74 | 61 (55-67) | 61 (55-71) | 41 | 39 |
| Belay[ | 20 | 14 | 57.7 ± 8.7 | 52.9 ± 10.8 | 1 | 2 |
| Hufeland[ | 11 | 9 | 52.8 ± 8.0 | 51.5 ± 9.5 | 7 | 2 |
| Mardani-Kivi[ | 29 | 33 | 54.5 ± 5.3 | 55.5 ± 5.2 | 9 | 11 |
| Oh[ | 27 | 31 | 61.04 (53-69) | 56.61 (42-76) | 18 | 10 |
| Kukkonen[ | 26 | 24 | 62.7 (F); 63.7 (M) | 54.1 (F); 54.9 (M) | 13 | 9 |
| De Carli[ | 30 | 35 | 59.6 ± 8.7 | 56.3 ± 3.9 | NG | NG |
| Koh[ | 41 | 43 | 66 (55-82) | 65 (55-77) | 32 | 27 |
| Aflatooni[ | 104 | 111 | 63.5 ± 8.6 | 58.9 ± 8.8 | 56 | 31 |
| Zhang[ | 18 | 22 | 62.2 ± 6.1 | 60.5 ± 6.3 | 12 | 14 |
| Kerschbaum[ | 36 | 49 | 69 ± 10 | 63 ± 11 | 23 | 17 |
| Meraner[ | 29 | 24 | 59.2 ± 9.2 | 57.6 ± 9.0 | 16 | 9 |
| Cho[ | 41 | 42 | 63.8 (44-68) | 58.6 (45-70) | 21 | 19 |
| Biz[ | 202 | 50 | 61.4 | 55.34 | 108 | 19 |
| Ikemoto[ | 55 | 22 | 58.05 | 58.18 | NG | NG |
| Sentürk[ | 10 | 10 | 63 | 57 | 5 | 4 |
| Wittstein[ | 19 | 16 | 62.5 ± 10.7 | 52.0 ± 14.3 | 9 | 12 |
| Boileau[ | 39 | 33 | 68 ± 6 | 68 ± 6 | NG | NG |
F, female; M, male; NG, not given.
Data are presented as mean, mean ± SD, or mean (range).
LHBT Injury Types, Rotator Cuff Injury Types, and Tenodesis Methods
| Lead Author (Year) | LHBT Injury Type | Rotator Cuff Injury Type | Tenodesis Method |
|---|---|---|---|
| MacDonald[ | LHBT lesion | Repairable rotator cuff, irreparable rotator cuff, no rotator cuff tear | Arthroscopic suprapectoral approach with interference screw or open subpectoral approach with button |
| Castricini[ | Tenosynovitis, subluxation, dislocation, partial tear | Grade I or II full-thickness repairable supraspinatus tendon tear | Interference screw |
| Lee[ | Partial tear | Small to medium rotator cuff tear | Interference screw |
| Zhang[ | Severe inflammation, hypertrophy, instability, partial-thickness tear, SLAP lesion | Small to large full-thickness rotator cuff tear | Suture anchor |
| Belay[ | Partial tear, subluxation | Small to large full-thickness rotator cuff tear | Interference screw |
| Hufeland[ | Isolated SLAP or biceps pulley lesion | — | Interference screw |
| Mardani-Kivi[ | Inflammation, partial tear, subluxation or SLAP lesion | Small to large full-thickness rotator cuff tear | Interference screw |
| Oh[ | Partial tear | Full-thickness supraspinatus (and infraspinatus) tendon tear, high-grade partial-thickness supraspinatus tendon tear, full-thickness subscapularis tendon tear with supraspinatus (and infraspinatus) tendon tear | Suture anchor |
| Kukkonen[ | Irritated/frayed and/or unstable biceps tendon | Full-thickness supraspinatus tendon tear | Nonabsorbable titanium suture anchor |
| De Carli[ | Degenerative tear, tenosynovitis, subluxation, SLAP lesion | Small to large rotator cuff tear | Suturing biceps tendon to rotator cuff tendon |
| Koh[ | Tear >30%, subluxation or dislocation or degenerative type 2 SLAP lesion | Rotator cuff tear | Suture anchor |
| Aflatooni[ | Proximal biceps or superior labral complex injury | Rotator cuff tear | Interference screw |
| Zhang[ | Inflammation | — | Suture anchor |
| Kerschbaum[ | Tendinitis, tear, subluxation or SLAP lesion | Rotator cuff tear | Suture anchor |
| Meraner[ | Complete or partial rupture or severe degeneration | Small to large full-thickness rotator cuff tear | Common suture anchor |
| Cho[ | LHBT lesion | Small to massive full-thickness rotator cuff tear | Ethibond suture |
| Biz[ | Tendinopathy, partial injury or instability | Rotator cuff tear | — |
| Ikemoto[ | LHBT injury | Rotator cuff tear | 2 anchors |
| Sentürk[ | Chronic biceps tenosynovitis | Small to medium rotator cuff tear | Bioabsorbable interference screw |
| Wittstein[ | LHBT lesion | Small to large full-thickness rotator cuff tear | — |
| Boileau[ | LHBT lesion | Irreparable rotator cuff tear | Bioabsorbable interference screw |
LHBT, long head of the biceps tendon; SLAP, superior labrum from anterior to posterior; —, none reported.
Risk of Bias for Randomized Clinical Trials Using the Cochrane Collaboration Tool
| Lead author |
| ||||||
|---|---|---|---|---|---|---|---|
| Study group 1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| MacDonald (2020)[ | + | + | + | ? | + | + | ? |
| Castricini (2018)[ | + | + | + | ? | - | + | + |
| Lee (2016)[ | + | + | ? | + | - | + | ? |
| Zhang (2015)[ | + | + | ? | + | + | + | + |
+ = clear documentation that the study meets this requirement, ? = unclear from publication, - = no evidence that requirements met.
Item No.: 1 = random sequence generation; 2 = allocation concealment; 3 = blinding of participants and personnel; 4 = blinding of outcomes; 5 = incomplete outcome data; 6 = selective reporting; and 7 = other bias.
Risk of Bias for Cohort Studies Using the Newcastle-Ottawa Scale
| Lead Author | Selection | Comparability | Outcome | Score | |||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 1 | 1 | 2 | 3 | ||
| Study group 2 | |||||||||
| Belay[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
| Hufeland[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
| Mardani-Kivi[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | 7 |
| Oh[ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | — | 6 |
| Kukkonen[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
| De Carli[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
| Koh[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
| Study group 3 | |||||||||
| Aflatooni[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 7 |
| Zhang[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 7 |
| Kerschbaum[ | ⋆ | ⋆ | ⋆ | ⋆ | — | — | ⋆ | ⋆ | 6 |
| Meraner[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 7 |
| Cho[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 7 |
| Biz[ | ⋆ | ⋆ | ⋆ | ⋆ | — | — | ⋆ | ⋆ | 6 |
| Ikemoto[ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 7 |
| Sentürk[ | ⋆ | ⋆ | ⋆ | ⋆ | — | — | ⋆ | ⋆ | 6 |
| Wittstein[ | — | ⋆ | ⋆ | ⋆ | ⋆ | — | ⋆ | ⋆ | 6 |
| Boileau[ | ⋆ | ⋆ | ⋆ | ⋆ | — | — | ⋆ | ⋆ | 6 |
A study can be awarded a maximum of 1 star for each numbered item within the Selection and Outcome categories. A maximum of 2 stars can be given for the Comparability category. The dashes denote ineligibility for a star.
Selection: 1 = representativeness of the exposed cohort; 2 = selection of the nonexposed cohort; 3 = ascertainment of exposure; and 4 = demonstration that the outcome of interest was not present at the start of the study.
Comparability: 1 = comparability of cohorts on the basis of the design or analysis.
Outcome: 1 = assessment of outcomes; 2 = follow-up was long enough for outcomes to occur; and 3 = adequacy of follow-up.
Tenotomy Versus Tenodesis Outcomes by Study Group
| Outcome | Study Group 1 | Study Group 2 | Study Group 3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RR or SMD (95% CI) |
|
| RR or SMD (95% CI) |
|
| RR or SMD (95% CI) |
|
| |
| Popeye deformity | 3.29 (1.92 to 5.49) | 0% | 0.23 (.97) | 2.35 (1.43 to 3.85) | 0% | 4.97 (.55) | 2.57 (1.33 to 4.98) | 45% | 14.60 (.07) |
| Arm cramping pain | 1.73 (0.61 to 4.92) | — | — | 3.16 (0.99 to 10.15) | 1% | 3.02 (.39) | 2.17 (1.20 to 3.95) | 0% | 1.15 (.56) |
| Rotator cuff retear | 1.03 (0.47 to 2.23) | 0% | 0.04 (.83) | 2.87 (0.61 to 13.61) | — | — | — | — | — |
| Constant score | –0.16 (–0.57 to 0.24) | 45% | 1.81 (.18) | –0.47 (–0.73 to –0.21) | 0% | 1.94 (.58) | –0.26 (–0.60 to 0.08) | 53% | 8.42 (.08) |
| VAS pain score | 0.04 (–0.18 to 0.26) | 0% | 1.26 (.53) | –0.36 (–1.33 to 0.60) | 79% | 4.77 (.03) | 0.26 (–0.37 to 0.89) | — | — |
| ASES score | 0.15 (–0.22 to 0.51) | — | — | –0.39 (–0.78 to 0.00) | 28% | 2.78 (.25) | 0.26 (–0.41 to 0.92) | — | — |
| Elbow flexion strength index | 0.00 (–0.32 to 0.32) | — | — | –0.02 (–0.35 to 0.31) | 0% | 0.35 (.56) | — | — | — |
| Forearm supination strength index | 0.00 (–0.32 to 0.32) | — | — | –0.75 (–1.28 to –0.21) | — | — | — | — | — |
| SST score | — | — | — | –0.60 (–0.94 to –0.27) | 0% | 1.91 (.39) | — | — | — |
| UCLA score | — | — | — | — | — | — | –0.18 (–0.55 to 0.19) | 14% | 2.31 (.31) |
| Forward flexion | — | — | — | 0.06 (–0.45 to 0.58) | — | — | –0.39 (–0.85 to 0.08) | — | — |
| External rotation at the side | — | — | — | 0.08 (–0.43 to 0.60) | — | — | –0.57 (–1.04 to –0.10) | — | — |
Group 1 = randomized clinical trials; group 2 = prospective cohort studies; and group 3 = retrospective cohort studies. I 2 and Q values quantify study heterogeneity. Dashes indicate no data or inadequate data available. ASES, American Shoulder and Elbow Surgeons; RR, risk ratio; SMD, standard mean difference; SST, Simple Shoulder Test; UCLA, University of California, Los Angeles; VAS, visual analog scale.
Significant results.
Figure 2.Forest plot displaying the risk ratio and 95% CI for the effect of treatment using tenotomy or tenodesis on the incidence of a Popeye deformity.
Figure 3.Forest plot displaying the risk ratio and 95% CI for the effect of treatment using tenotomy or tenodesis on the incidence of arm cramping pain.
Figure 4.Forest plot displaying the risk ratio and 95% CI for the effect of treatment using tenotomy or tenodesis on the incidence of rotator cuff retears.
Figure 5.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on the Constant score.
Figure 6.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on the visual analog scale pain score.
Figure 7.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on the American Shoulder and Elbow Surgeons score.
Figure 8.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on elbow flexion strength index.
Figure 9.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on forearm supination strength index.
Figure 10.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on the Simple Shoulder Test score.
Figure 11.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on the University of California, Los Angeles score.
Figure 12.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on forward flexion.
Figure 13.Forest plot displaying the standardized mean difference (SMD) and 95% CI for the effect of treatment using tenotomy or tenodesis on external rotation at the side.